ArticleEMBO molecular medicine2019

The novel BET-CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild-type prostate cancer.

Yuqian Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.